Source: FinanzNachrichten

Endotronix: Endotronix, Inc.: ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM

NAPERVILLE, Ill., Sept. 28, 2024 /PRNewswire/ -- Endotronix, an Edwards Lifesciences company (NYSE: EW), today announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes for th...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Harry D. Rowland's photo - Co-Founder & CEO of Endotronix

Co-Founder & CEO

Harry D. Rowland

CEO Approval Rating

88/100

Read more